232 related articles for article (PubMed ID: 22193343)
1. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
Arasli M; Ustundag Y; Delikanli B; Harmandar F; Buyukuysal C
Hepatogastroenterology; 2012 May; 59(115):851-7. PubMed ID: 22193343
[TBL] [Abstract][Full Text] [Related]
2. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.
You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Li YL; Lei H; Liu J; Chen HY; Tang BZ; Huang JH
BMC Infect Dis; 2008 Sep; 8():123. PubMed ID: 18803883
[TBL] [Abstract][Full Text] [Related]
3. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
Lau GK; Cooksley H; Ribeiro RM; Powers KA; Shudo E; Bowden S; Hui CK; Anderson J; Sorbel J; Mondou E; Rousseau F; Lewin S; Perelson AS; Locornini S; Naoumov NV
Antivir Ther; 2007; 12(5):705-18. PubMed ID: 17713154
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
Chen LY; Zhu LY; Yang BS; Bi MR; Yan BZ; Wang W; Ma YJ
Hepatogastroenterology; 2012; 59(120):2582-6. PubMed ID: 22626879
[TBL] [Abstract][Full Text] [Related]
5. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
Deng M; Li MH; Liu SA; Liu F; Sang Y; Song SJ; Zang SF; Guan XP; Yao X; Wu XP; Cheng J; Xu DZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):21-3. PubMed ID: 20848841
[TBL] [Abstract][Full Text] [Related]
6. Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.
van der Eijk AA; Hansen BE; Niesters HG; Janssen HL; van de Ende M; Schalm SW; de Man RA
J Viral Hepat; 2005 Jul; 12(4):364-72. PubMed ID: 15985006
[TBL] [Abstract][Full Text] [Related]
7. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
[TBL] [Abstract][Full Text] [Related]
8. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
[TBL] [Abstract][Full Text] [Related]
10. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.
Yang G; Liu A; Xie Q; Guo TB; Wan B; Zhou B; Zhang JZ
Int Immunol; 2007 Feb; 19(2):133-40. PubMed ID: 17182968
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation.
Wang Y; Liu Y; Han R; Li Q; Yao Z; Niu W; Yuan Y; Tang Z; Zhu Z; Shen Z
J Gastroenterol Hepatol; 2010 Jan; 25(1):138-42. PubMed ID: 19817952
[TBL] [Abstract][Full Text] [Related]
12. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
Yan Z; Zhou J; Zhang M; Fu X; Wu Y; Wang Y
Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.
Stoop JN; Claassen MA; Woltman AM; Binda RS; Kuipers EJ; Janssen HL; van der Molen RG; Boonstra A
Clin Immunol; 2008 Dec; 129(3):419-27. PubMed ID: 18823821
[TBL] [Abstract][Full Text] [Related]
14. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
Li CZ; Hu JJ; Xue JY; Yin W; Liu YY; Fan WH; Xu H; Liang XS
World J Gastroenterol; 2014 Jul; 20(28):9486-96. PubMed ID: 25071343
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients.
Daudé M; Rostaing L; Sauné K; Lavayssière L; Basse G; Esposito L; Guitard J; Izopet J; Alric L; Kamar N
Transplantation; 2011 Apr; 91(8):916-20. PubMed ID: 21325995
[TBL] [Abstract][Full Text] [Related]
16. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.
El-Badawy O; Sayed D; Badary MS; Abd-Alrahman ME; El-Feky MA; Thabit AG
Hum Immunol; 2012 Apr; 73(4):335-41. PubMed ID: 22342871
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate.
TrehanPati N; Kotillil S; Hissar SS; Shrivastava S; Khanam A; Sukriti S; Mishra SK; Sarin SK
J Clin Immunol; 2011 Jun; 31(3):509-20. PubMed ID: 21305387
[TBL] [Abstract][Full Text] [Related]
18. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients.
Wu W; Li J; Chen F; Zhu H; Peng G; Chen Z
J Gastroenterol Hepatol; 2010 Apr; 25(4):750-7. PubMed ID: 20492330
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
20. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]